Breast Tumors Exploit Fat Cells for Growth: Can We Halt This Process?

UCSF researchers reveal how aggressive breast tumors hijack nearby fat cells by forming molecular tunnels to access energy, offering new potential for targeted therapies.
Recent research from UCSF has uncovered a troubling mechanism by which aggressive breast cancers, particularly triple-negative types, hijack surrounding fat cells to fuel their growth. Scientists observed that tumor cells form molecular bridges known as gap junctions into nearby fat cells. Through these connections, the cancer cells send signals that prompt fat cells to release stored energy, which then nourishes and accelerates tumor development. Remarkably, when these gap junctions are blocked experimentally, tumor growth significantly slows down, providing a promising target for future therapies.
The study involved analyzing breast cancer tissues from patients and laboratory models, revealing that tumor cells actively manipulate the fat environment to their advantage. As tumors expand, the fat cells around them shrink—a sign of energy exploitation. These findings suggest that interrupting the communication channels between cancer cells and adipocytes could serve as an effective strategy against the deadliest breast cancer forms.
Currently, drugs that inhibit gap junctions are being tested in clinical trials for brain cancer, raising hope that similar approaches could be adapted for breast cancer treatment. This discovery offers a vital insight into cancer biology and opens avenues for developing therapies that can starve tumors by cutting off their energy supply.
Overall, this research highlights the importance of understanding tumor interactions with the surrounding tissue and suggests that targeting these interactions could help halt the progression of aggressive breast cancers.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Legal Barriers Limit Harm-Reduction Efforts for Methamphetamine Users in New Zealand
Legal restrictions in New Zealand prevent distributing safer smoking kits for methamphetamine users, limiting harm reduction efforts despite international evidence supporting their benefits for health and safety.
Novo Nordisk Acquires US BioTech Leader Akero for $4.7 Billion to Advance Metabolic Disease Treatments
Novo Nordisk has acquired US biotech firm Akero Therapeutics for $4.7 billion, aiming to develop groundbreaking treatments for metabolic diseases like fatty liver and obesity. The deal emphasizes innovation in managing liver damage and expanding therapies for millions worldwide.
Innovative AI Model Enhances Detection of Cancer Cell Signs
A new AI model by the Chan Zuckerberg Initiative, GREmLN, advances early detection of cancer by analyzing cellular gene networks, promising breakthroughs in diagnosis and treatment. | source: https://medicalxpress.com/news/2025-07-ai-scientists-cancer-cells.html
Potential Risks of Medicaid Cuts for Cancer Survivors
Recent proposed Medicaid reductions threaten to leave thousands of cancer survivors without vital health coverage, risking delayed diagnoses and costly treatments. Learn about the potential impact and ongoing political battles.



